CEPI to provide up to $19.3 m to Bharat Biotech, others for development of ‘variant-proof’ Covid vaccine
The Coalition for Epidemic Preparedness Innovations (CEPI) on Tuesday announced a $200-million programme for the development of vaccines that provide broad protection against SARS-CoV-2 variants and other beta coronaviruses. CEPI will provide funding of up to $19.3 million to support the development of a ‘variant-proof’ SARS-CoV-2 vaccine candidate to an international multi-disciplinary consortium comprising Bharat … Read more